Artrya Limited (ASX:AYA)
Australia · Delayed Price · Currency is AUD 3.290
0.00 (0.00%)
Oct 17, 2025, 4:10 PM AEST
Artrya Revenue
In the fiscal year ending June 30, 2025, Artrya had annual revenue of 28 thousand AUD. Artrya had revenue of 15 thousand in the half year ending June 30, 2025.
Revenue
28.00K
Revenue Growth
n/a
P/S Ratio
17,718.52
Revenue / Employee
n/a
Employees
n/a
Market Cap
496.12M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 28.00K | - | - |
| Jun 30, 2024 | - | - | - |
| Jun 30, 2023 | - | - | - |
| Jun 30, 2022 | - | - | - |
| Jun 30, 2021 | - | - | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Ramsay Health Care | 17.79B |
| Sonic Healthcare | 9.65B |
| Ansell | 3.06B |
| Cochlear | 2.34B |
| Regis Healthcare | 1.16B |
| Telix Pharmaceuticals | 1.01B |
| Neuren Pharmaceuticals | 218.86M |